Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
India News
Combined APAO-AIOS Meeting Draws 12,500 to New Convention Center in India
Around 12,500 delegates attended the 2025 joint meeting of the Asia-Pacific Academy of Ophthalmology and All-India Ophthalmolog-ical Society, with more than 1,300 international visitors. The confer...
Asia-Pacific Leads Push to Get AI from the Bench to the Bedside
Bridging the gap between artificial intelligence development and deployment in ophthalmology was the main theme of a Thursday morning session on AI innovation at the 2025 APAO-AIOS meeting. Paisan ...
2025-2026 Ophthalmic Meetings Calendar
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
Indian Glaucoma Surgeons Embrace MIGS Procedures Over Devices
Most MIGS (minimally invasive glaucoma surgery) sessions at major ophthalmic meetings talk about devices. Indian doctors at the MIGS sessions of the joint APAO-AIOS congress in April mostly talked ...
Cipla to Market Clobetasol Drops in 11 Countries, Including India, Under License with Formosa
Indian company Cipla has obtained exclusive rights to market clobetasol propionate eye drops in 11 countries, including India, for inflammation and pain following ocular surgery under a license agr...
2024 in Review: Warburg Pincus Buys Controlling Stake in India’s Appasamy
US-based private equity firm Warburg Pincus re-entered the ophthalmic industry in April 2024 when it bought a controlling stake in India’s Appasamy Associates. Financial details were not disclosed,...
October 2024 Ophthalmic News Briefs
Oculus has announced the addition of frequency doubling perimetry (FDP) to its Easyfield VR visual field diagnostic headset. The German ophthalmic diagnostic company, with US headquarters in Arling...
Indian Regulators Approve First Ophthalmic AI Software—Medios DR from Remidio
India’s Remidio announced Sept. 13 that regulators there had approved its Medios DR software for autonomous detection of diabetic retinopathy (DR). Medios DR becomes the first ophthalmic artificial...
US FDA Grants Tentative Approval to Generic Brimonidine Tartrate Ophthalmic Solution (Lumify) from Lupin
Indian drugmaker Lupin announced Aug. 14 that it had received tentative approval from the US FDA for its abbreviated new drug application for brimonidine tartrate ophthalmic solution 0.025%, a gene...
US FDA Approves Generic Prednisolone Acetate Drops from India’s Lupin for Ocular Inflammation
Indian drugmaker Lupin announced Aug. 5 that the US FDA had approved its abbreviated new drug application for prednisolone acetate ophthalmic suspension, 1%, a generic equivalent of AbbVie’s Pred F...
July 2024 Ophthalmic News Briefs
Bausch + Lomb announced July 23 that it had acquired dry eye diagnostic company Trukera Medical from its private equity owner, AccelMed Partners, and other shareholders. No financial details were d...
RevOpsis Enlists India’s Kemwell Biopharma to Manufacture Wet AMD Candidate
RevOpsis Therapeutics, of San Carlos, California, announced June 17 that it had entered into a strategic manufacturing partnership with India’s Kemwell Biopharma. The deal aims to accelerate develo...
May 2024 Ophthalmic News Briefs
Taiwan-based Formosa Pharmaceuticals announced May 9 that it had entered into an exclusive licensing agreement with Tabuk Pharmaceuticals to market clobetasol propionate 0.05% eye drops for post-su...
Outlook Leads Latest Ophthalmic Fundraising with $164M in Private Placements
Retinal drug developer Outlook Therapeutics led recent ophthalmic fundraising efforts with two private placements, for proceeds totaling $164 million. Financing announced in the past four weeks tot...
Warburg Pincus Buys Controlling Stake in India’s Appasamy
US-based private equity firm Warburg Pincus and Appasamy Associates announced April 10 that Warburg had bought a controlling stake in the Indian ophthalmic company. Financial details were not discl...
Emerging Companies Pursuing Ophthalmic Indications, April 2024
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
US Private Equity Firm Warburg Pincus Buys Controlling Stake in India’s Appasamy
US-based private equity firm Warburg Pincus and Appasamy Associates announced April 10 that Warburg had bought a controlling stake in the Indian ophthalmic company. Financial details were not discl...
2024 APAO Congress Brainstorms How to Expand Access to Eye Care; Companies Showcase Tech Boom
Nearly 7,800 delegates attended the 2024 congress of the Asia-Pacific Academy of Ophthalmology in southern Bali from Feb. 22-25. The 253 sessions and 120 exhibits spread across four floors in two n...
Alcon Launches Clareon PC-IOLs in India
Alcon announced March 12 that it had launched presbyopia-correcting intraocular lenses (IOLs) in India made of the Clareon glistening-free material. The Clareon platform is available in India in tw...
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations
Alcon reported March 6 that the AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) had surpassed more than 1 million implantations worldwide. Alcon, a Swi...
Eye Ointments Sold at Walmart, CVS Recalled Due to Infection Risk
India’s Brassica Pharma announced Feb. 12 that it was voluntarily recalling eye ointments sold by retailers such as Walmart and CVS due to a danger of infection. The company said an inspection by t...
India Orders Tougher Drug-Making Standards After Overseas Deaths
Prime Minister Narendra Modi’s government has stepped up scrutiny of India’s pharmaceutical factories after being stung by a series of overseas deaths linked to Indian-made drugs. The news agency R...
India Orders Tougher Drug-Making Standards After Overseas Deaths
Prime Minister Narendra Modi’s government has stepped up scrutiny of India’s pharmaceutical factories after being stung by a series of overseas deaths linked to Indian-made drugs. The news agency R...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.